Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 1/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.41 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | OGA | O60502 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | FGF1 | P05230 | 1/20 | 0.38 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18390837 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 | |
| SCHEMBL6157450 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 | |
| SCHEMBL767465 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 | |
| SCHEMBL13446418 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 | |
| SCHEMBL767424 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 | |
| SCHEMBL14479870 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 | |
| SCHEMBL3269920 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 | |
| SCHEMBL505006 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 | |
| SCHEMBL1985946 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 | |
| SCHEMBL248110 | 1.00 | PYGB (0.43) | PYGBLGALS8LGALS1LGALS3LGALS9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 324 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4330357-B1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | VERTORO B V (NL) | 2024-11-06 | — | — | EP | claimed |
| US-12116539-B2 | Composition comprising heavy petroleum oil | VERTORO B.V. (NL) | 2024-10-15 | — | — | US | claimed |
| EP-4038078-B1 | A METHOD FOR OBTAINING A LIGNIN OIL COMPOSITION USING A COMPRESSED GAS AND ACID ASSISTED PROCESS | VERTORO B V (NL) | 2024-07-24 | — | — | EP | claimed |
| US-20240218275-A1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | VERTORO B.V. (NL) | 2024-07-04 | — | — | US | claimed |
| CN-118048204-A | Wafer cleaning liquid for cleaning copper surface after chemical mechanical planarization | 华中科技大学 | 2024-05-17 | — | — | CN | claimed |
| EP-4330357-A1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | Vertoro B.V. (NL) | 2024-03-06 | — | — | EP | claimed |
| CN-117449805-A | Method for using oil-gas well blocking remover | 中国石油天然气股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117343708-A | Hydrate blocking removing liquid and filling method thereof | 中国石油天然气股份有限公司 | 2024-01-05 | — | — | CN | claimed |
| WO-2022229333-A1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | VERTORO B.V. (NL) | 2022-11-03 | — | — | WO | claimed |
| EP-4083172-A1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | Vertoro B.V. (NL) | 2022-11-02 | — | — | EP | claimed |
| CN-114555616-A | Method for preparing lignin oil composition by using compressed gas and acid-assisted process | 沃特罗有限公司 | 2022-05-27 | — | — | CN | claimed |
| EP-2812007-A1 | MATERIALS AND METHODS FOR TREATING DIARRHEA | University of Florida Research Foundation, Inc. (US) | 2014-12-17 | — | — | EP | claimed |
| WO-2013119917-A1 | MATERIALS AND METHODS FOR TREATING DIARRHEA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2013-08-15 | — | — | WO | claimed |
| EP-1151126-B1 | BIOCATALYTIC SYNTHESIS OF SHIKIMIC ACID | UNIV MICHIGAN STATE (US) | 2011-06-29 | — | — | EP | claimed |
| US-7758150-B2 | Capture member and ink jet printer | SEIKO EPSON CORPORATION (JP) | 2010-07-20 | — | — | US | claimed |
| US-20040040472-A1 | Method of recycling cement kiln dust | PNC BANK, NATIONAL ASSOCIATION | 2004-03-04 | — | — | US | claimed |
| EP-1277710-A1 | Process for preparing a flowable slurry | DOW CORNING CORPORATION (US) | 2003-01-22 | — | — | EP | claimed |
| US-6478870-B2 | CEMENTS | DOW CORNING CORPORATION | 2002-11-12 | — | — | US | claimed |
| US-20020033121-A1 | Process aid for preparing a flowable slurry | DOW CORNING CORPORATION | 2002-03-21 | — | — | US | claimed |
| US-20260130973-A1 | COMPOSITIONS AND METHODS FOR DEGRADATION OF LIPOFUSCIN CYCLORETINAL BY MSP1 | TEXAS A & M UNIV SYS (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260062633-A1 | EMULSION | QUADRISE INTERNATIONAL LTD (GB) | 2026-03-05 | — | — | US | disclosed |
| EP-4598562-A2 | COMPOSITIONS AND METHODS FOR DEGRADATION OF LIPOFUSCIN CYCLORETINAL BY MSP1 | The Texas A&M University System (US) | 2025-08-13 | — | — | EP | disclosed |
| EP-4330357-B1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | VERTORO B V (NL) | 2024-11-06 | — | — | EP | disclosed |
| US-12116539-B2 | Composition comprising heavy petroleum oil | VERTORO B.V. (NL) | 2024-10-15 | — | — | US | disclosed |
| CN-118581002-A | Novel phosphorus-dissolving algae-dissolving strain GXAS 306,306 and application thereof in prevention and treatment of harmful algae bloom | 广西科学院 | 2024-09-03 | — | — | CN | disclosed |
| US-20240218275-A1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | VERTORO B.V. (NL) | 2024-07-04 | — | — | US | disclosed |
| CN-118048204-A | Wafer cleaning liquid for cleaning copper surface after chemical mechanical planarization | 华中科技大学 | 2024-05-17 | — | — | CN | disclosed |
| WO-2024077259-A2 | COMPOSITIONS AND METHODS FOR DEGRADATION OF LIPOFUSCIN CYCLORETINAL BY MSP1 | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2024-04-11 | — | — | WO | disclosed |
| CN-115948276-B | Lactobacillus plantarum S165 and application thereof in conversion and synthesis of rare notoginsenoside R2 from fermented notoginsenoside R1 | 吉林省农业科学院 | 2024-04-02 | — | — | CN | disclosed |
| EP-4330357-A1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | Vertoro B.V. (NL) | 2024-03-06 | — | — | EP | disclosed |
| CN-117449805-A | Method for using oil-gas well blocking remover | 中国石油天然气股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117449806-A | Carbonate reservoir hydrocarbon well yield-increasing and blocking-removing liquid and use method thereof | 中国石油天然气股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117384610-A | Blocking remover for complex lithology environment and blocking removing method thereof | 中国石油天然气股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-117345181-A | Blocking removing liquid for oil and gas field exploitation and filling method thereof | 中国石油天然气股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117343708-A | Hydrate blocking removing liquid and filling method thereof | 中国石油天然气股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117310180-A | Sample processing method for detecting Cys C by MALDI-TOF MS and application thereof | 融智生物科技（青岛）有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-117310182-A | Sample processing kit for detecting Cys C by MALDI-TOF MS and application thereof | 融智生物科技（青岛）有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-115093992-B | Lactobacillus plantarum GLP40 and application thereof in preparation of rare ginsenoside Rk3 through fermentation conversion | 吉林省农业科学院 | 2023-07-07 | — | — | CN | disclosed |
| CN-115029279-B | Lactobacillus plantarum MB11 and application thereof in biotransformation preparation of rare ginsenoside | 吉林省农业科学院 | 2023-06-06 | — | — | CN | disclosed |
| EP-4176072-A1 | PROCESS FOR PREPARING ALKYL POLYGLUCOSIDES, AND ALKYL POLYGLUCOSIDES OBTAINED ACCORDING TO THE PROCESS | Institut National des Sciences Appliquées de Toulouse (FR) | 2023-05-10 | — | — | EP | disclosed |
| US-20230113413-A1 | POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS | NEKTAR THERAPEUTICS (US) | 2023-04-13 | — | — | US | disclosed |
| CN-115948276-A | Lactobacillus plantarum S165 and application thereof in conversion synthesis of rare notoginsenoside R2 by fermenting notoginsenoside R1 | 吉林省农业科学院 | 2023-04-11 | — | — | CN | disclosed |
| WO-2023003175-A1 | NOVEL LACTOBACILLUS PARACASEI ATG-E1 STRAIN OR COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING RESPIRATORY DISEASE | (주)에이투젠 | 2023-01-26 | — | — | WO | disclosed |
| WO-2022229333-A1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | VERTORO B.V. (NL) | 2022-11-03 | — | — | WO | disclosed |
| EP-4083172-A1 | COMPOSITION COMPRISING HEAVY PETROLEUM OIL | Vertoro B.V. (NL) | 2022-11-02 | — | — | EP | disclosed |
| CN-115093992-A | Lactobacillus plantarum GLP40 and application thereof in preparation of rare ginsenoside Rk3 through fermentation and transformation | 吉林省农业科学院 | 2022-09-23 | — | — | CN | disclosed |
| US-11446385-B2 | Polymer derivatives having particular atom arrangements | NEKTAR THERAPEUTICS (US) | 2022-09-20 | — | — | US | disclosed |
| CN-115029279-A | Lactobacillus plantarum MB11 and application thereof in biotransformation preparation of rare ginsenoside | 吉林省农业科学院 | 2022-09-09 | — | — | CN | disclosed |
| CN-114555616-A | Method for preparing lignin oil composition by using compressed gas and acid-assisted process | 沃特罗有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-110272850-B | New strain with algae dissolving capacity and application thereof to phaeocystis globosa | 广西科学院 | 2022-05-17 | — | — | CN | disclosed |
| WO-2022003305-A1 | PROCESS FOR PREPARING ALKYL POLYGLUCOSIDES, AND ALKYL POLYGLUCOSIDES OBTAINED ACCORDING TO THE PROCESS | INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE (FR) | 2022-01-06 | — | — | WO | disclosed |
| US-20210388015-A1 | GLUCOPYRANOSE DERIVATIVES USEFUL AS SGLT2 INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2021-12-16 | — | — | US | disclosed |
| US-20210388016-A1 | GLUCOPYRANOSE DERIVATIVES USEFUL AS SGLT2 INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2021-12-16 | — | — | US | disclosed |
| US-11147219-B2 | Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, process and systems for the same | INNOVATION HAMMER, LLC (US) | 2021-10-19 | — | — | US | disclosed |
| US-20210238170-A1 | 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators | JANSSEN PHARMACEUTICA NV (BE) | 2021-08-05 | — | — | US | disclosed |
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-06-10 | — | — | US | disclosed |
| WO-2021105619-A1 | WATER-BASED HYDROGEL, AND REACTION PRODUCT OF ISOSORBIDE EPOXIDE AND AMINES | ROQUETTE FRERES (FR) | 2021-06-03 | — | — | WO | disclosed |
| US-11014917-B2 | 5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators | JANSSEN PHARMACEUTICA NV (BE) | 2021-05-25 | — | — | US | disclosed |
| EP-2401389-B1 | SYNTHESIS OF LONG-CHAIN ALKYL GLYCOSIDES | ENZA BIOTECH AB (SE) | 2021-04-14 | — | — | EP | disclosed |
| EP-3783093-A2 | METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES | Innovation Hammer LLC (US) | 2021-02-24 | — | — | EP | disclosed |
| US-10815210-B2 | Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators | JANSSEN PHARMACEUTICA NV (BE) | 2020-10-27 | — | — | US | disclosed |
| EP-3717463-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | Sanofi (FR) | 2020-10-07 | — | — | EP | disclosed |
| EP-2782990-B1 | METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES | INNOVATION HAMMER LLC (US) | 2020-10-07 | — | — | EP | disclosed |
| US-20200291004-A1 | 5-FLUORO-C-(ARYL OR HETEROCYCLYL)-GLYCOSIDE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-09-17 | — | — | US | disclosed |
| US-20200246471-A1 | POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS | NEKTAR THERAPEUTICS (US) | 2020-08-06 | — | — | US | disclosed |
| CN-111433193-A | Novel conjugates of agents and moieties capable of binding to glucose sensing proteins | 赛诺菲 | 2020-07-17 | — | — | CN | disclosed |
| WO-2020135898-A1 | SYNTHETIC OLIGOSACCHARIDE DERIVATIVES AS A VACCINE AGAINST BORDETELLA PERTUSSIS | INSTITUTO FINLAY DE VACUNAS (CU) | 2020-07-02 | — | — | WO | disclosed |
| US-10696662-B2 | 5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators | JANSSEN PHARMACEUTICA NV (BE) | 2020-06-30 | — | — | US | disclosed |
| US-10646578-B2 | Polymer derivatives having particular atom arrangements | NEKTAR THERAPEUTICS (US) | 2020-05-12 | — | — | US | disclosed |
| US-20200113143-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER LLC (US) | 2020-04-16 | — | — | US | disclosed |
| WO-2019215633-A1 | 5,5-DIFLUORO- AND 5-FLUORO-5-METHYL-C-GLYCOSIDE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2019-11-14 | — | — | WO | disclosed |
| CN-107556276-B | C-triaryl glucoside compound and preparation method and application thereof | 广州医科大学 | 2019-05-14 | — | — | CN | disclosed |
| EP-3463480-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | Sanofi (FR) | 2019-04-10 | — | — | EP | disclosed |
| US-10253010-B2 | C-glycoside derivative | SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. (CN) | 2019-04-09 | — | — | US | disclosed |
| EP-2644206-B1 | PEG derivatives containing two PEG chains | NEKTAR THERAPEUTICS (US) | 2019-04-03 | — | — | EP | disclosed |
| EP-3033442-B1 | METHODS FOR THE SIMULTANEOUS ELECTROLYTIC DECARBOXYLATION AND REDUCTION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORP (US) | 2019-04-03 | — | — | EP | disclosed |
| CN-105473765-B | Make the method for sugared electrolytic decarbodylation and reduction simultaneously | DFI 美国有限责任公司 | 2019-03-29 | — | — | CN | disclosed |
| US-20190055226-A1 | 5-FLUORO-C-(ARYL OR HETEROCYCLYL)-GLYCOSIDE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2019-02-21 | — | — | US | disclosed |
| EP-2971254-B1 | METHODS FOR THE ELECTROLYTIC DECARBOXYLATION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORP (US) | 2019-02-20 | — | — | EP | disclosed |
| US-20190022236-A1 | POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS | NEKTAR THERAPEUTICS | 2019-01-24 | — | — | US | disclosed |
| CN-105283585-B | Electrolytic decarboxylation method for saccharides | DFI 美国有限责任公司 | 2019-01-18 | — | — | CN | disclosed |
| US-20180325045-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER LLC (US) | 2018-11-15 | — | — | US | disclosed |
| EP-2512506-B1 | PARASITE VACCINE | MOREDUN RES INSTITUTE (GB) | 2018-08-29 | — | — | EP | disclosed |
| US-10010029-B2 | Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same | INNOVATION HAMMER, LLC (US) | 2018-07-03 | — | — | US | disclosed |
| WO-2018089449-A1 | BENZOCYCLOBUTANE DERIVATIVES USEFUL AS DUAL SGLT1/SGLT2 MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-17 | — | — | WO | disclosed |
| US-20180118884-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | UNIV KING ABDULLAH SCI & TECH (SA) | 2018-05-03 | — | — | US | disclosed |
| US-9957620-B2 | Methods for the simultaneous electrolytic decarboxylation and reduction of sugars | DFI USA, LLC (US) | 2018-05-01 | — | — | US | disclosed |
| US-9913913-B2 | Method for preparing a polymeric reagent | NEKTAR THERAPEUTICS (US) | 2018-03-13 | — | — | US | disclosed |
| US-9914688-B2 | Optically pure benzyl-4-chlorophenyl-C-glucoside derivative | SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. (CN) | 2018-03-13 | — | — | US | disclosed |
| EP-3283498-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | King Abdullah University Of Science And Technology (SA) | 2018-02-21 | — | — | EP | disclosed |
| US-9702047-B2 | Methods for the electrolytic decarboxylation of sugars | DYNAMIC FOOD INGREDIENTS CORPORATION (US) | 2017-07-11 | — | — | US | disclosed |
| US-9695269-B2 | Preparation of polyurethanes and polyesters from glycolipid type compounds | UNIVERSITÉ DE BORDEAUX (FR) | 2017-07-04 | — | — | US | disclosed |
| US-20170164562-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER LLC (US) | 2017-06-15 | — | — | US | disclosed |
| US-20170101388-A1 | C-GLYCOSIDE DERIVATIVE | Xuanzhu Pharma Co., Ltd. (CN) | 2017-04-13 | — | — | US | disclosed |
| US-9562029-B2 | C-glycoside derivatives | Xuanzhu Pharma Co., Ltd. (CN) | 2017-02-07 | — | — | US | disclosed |
| US-20160324974-A1 | METHOD FOR PREPARING A POLYMERIC REAGENT | NEKTAR THERAPEUTICS | 2016-11-10 | — | — | US | disclosed |
| WO-2016166682-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2016-10-20 | — | — | WO | disclosed |
| EP-2725031-B1 | C-GLYCOSIDE DERIVATIVES | XUANZHU PHARMA CO LTD (CN) | 2016-08-03 | — | — | EP | disclosed |
| US-9399070-B2 | Compositions comprising a polymeric reagent and a pharmacologically active agent | NEKTAR THERAPEUTICS (US) | 2016-07-26 | — | — | US | disclosed |
| US-20160194264-A1 | OPTICALLY PURE BENZYL-4-CHLOROPHENYL-C-GLUCOSIDE DERIVATIVE | Xuanzhu Pharma Co., Ltd. (CN) | 2016-07-07 | — | — | US | disclosed |
| US-20160194765-A1 | METHODS FOR THE SIMULTANEOUS ELECTROLYTIC DECARBOXYLATION AND REDUCTION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORPORATION (US) | 2016-07-07 | — | — | US | disclosed |
| US-9374955-B2 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC (US) | 2016-06-28 | — | — | US | disclosed |
| EP-3033442-A1 | METHODS FOR THE SIMULTANEOUS ELECTROLYTIC DECARBOXYLATION AND REDUCTION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORP. (US) | 2016-06-22 | — | — | EP | disclosed |
| EP-2891654-B1 | Optically pure benzyl-4-chlorophenyl-C-glucoside derivatives as SGLT inhibitors (diabetes mellitus) | XUANZHU PHARMA CO LTD (CN) | 2016-06-22 | — | — | EP | disclosed |
| EP-2585541-B1 | SEMI-INTERPENETRATING POLYMER NETWORK | 3M INNOVATIVE PROPERTIES CO (US) | 2016-06-08 | — | — | EP | disclosed |
| CN-105637084-A | New lactic acid bacterium, natural immunostimulant having new lactic acid bacterium as active ingredient, and food or drink containing new lactic acid bacterium | GENOME PHARMACEUTICALS INST CO LTD | 2016-06-01 | — | — | CN | disclosed |
| EP-3017059-A1 | A METHOD FOR DETERMINING THE VASE LIFE OR STORAGE HISTORY OF ONE OR MORE CUT FLOWERS, WHEREIN THE METHOD COMPRISES ASSAYING XYLOSE CONCENTRATION OR BETA-XYLOSIDASE EXPRESSION/ACTIVITY | Stichting Dienst Landbouwkundig Onderzoek (NL) | 2016-05-11 | — | — | EP | disclosed |
| US-9315438-B2 | Optically pure benzyl-4-chlorophenyl-C-glucoside derivative | XUANZHU PHARMA CO., LTD (CN) | 2016-04-19 | — | — | US | disclosed |
| US-9277697-B2 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC (US) | 2016-03-08 | — | — | US | disclosed |
| CN-103184170-B | A kind of novel lactobacillus casei LY-73 and application thereof | BGI SHENZHEN (CN) | 2016-03-02 | — | — | CN | disclosed |
| EP-2046877-B1 | METHOD OF MAKING MACROPOROUS CATION EXCHANGE RESINS | 3M INNOVATIVE PROPERTIES CO (US) | 2016-02-17 | — | — | EP | disclosed |
| US-20160024668-A1 | METHODS FOR THE ELECTROLYTIC DECARBOXYLATION OF SUGARS | DFI USA, LLC | 2016-01-28 | — | — | US | disclosed |
| EP-2971254-A1 | METHODS FOR THE ELECTROLYTIC DECARBOXYLATION OF SUGARS | Dynamic Food Ingredients Corporation (US) | 2016-01-20 | — | — | EP | disclosed |
| US-20150328331-A1 | Compositions Comprising a Polymeric Reagent and a Pharmacologically Active Agent | NEKTAR THERAPEUTICS (US) | 2015-11-19 | — | — | US | disclosed |
| US-20150250171-A1 | Compositions And Methods For Anti-Transpiration In Plants | INNOVATION HAMMER LLC (US) | 2015-09-10 | — | — | US | disclosed |
| US-20150250117-A1 | Compositions And Methods For Anti-Transpiration In Plants | INNOVATION HAMMER LLC (US) | 2015-09-10 | — | — | US | disclosed |
| EP-2764005-B1 | PREPARATION OF POLYURETHANES AND POLYESTERS FROM GLYCOLIPID TYPE COMPOUNDS | UNIV BORDEAUX (FR) | 2015-08-12 | — | — | EP | disclosed |
| US-9078841-B2 | Parasite vaccine | MOREDUN RESEARCH INSTITUTE (GB) | 2015-07-14 | — | — | US | disclosed |
| US-20150191502-A1 | OPTICALLY PURE BENZYL-4-CHLOROPHENYL-C-GLUCOSIDE DERIVATIVE | Xuanzhu Pharma Co., Ltd. (CN) | 2015-07-09 | — | — | US | disclosed |
| EP-2891654-A1 | Optically pure benzyl-4-chlorophenyl-C-glucoside derivatives as SGLT inhibitors (diabetes mellitus) | Xuanzhu Pharma Co., Ltd. (CN) | 2015-07-08 | — | — | EP | disclosed |
| US-9072304-B2 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC (US) | 2015-07-07 | — | — | US | disclosed |
| US-9056316-B2 | Semi-interpenetrating polymer network | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-06-16 | — | — | US | disclosed |
| EP-2701514-B1 | MODIFICATION OF TREHALOSE-6-PHOSPHATE LEVELS IN PLANTS | ISIS INNOVATION (GB) | 2015-06-10 | — | — | EP | disclosed |
| US-9044516-B2 | Pharmaceutical compositions of conjugates formed from polymer derivatives having particular atom arrangements | NEKTAR THERAPEUTICS (US) | 2015-06-02 | — | — | US | disclosed |
| WO-2015000983-A1 | A METHOD FOR DETERMINING THE VASE LIFE OR STORAGE HISTORY OF ONE OR MORE CUT FLOWERS, WHEREIN THE METHOD COMPRISES ASSAYING XYLOSE CONCENTRATION OR BETA-XYLOSIDASE EXPRESSION/ACTIVITY | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2015-01-08 | — | — | WO | disclosed |
| US-20140331555-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER, LLC | 2014-11-13 | — | — | US | disclosed |
| WO-2014164523-A1 | METHODS FOR THE ELECTROLYTIC DECARBOXYLATION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORPORATION (US) | 2014-10-09 | — | — | WO | disclosed |
| EP-2782990-A1 | METHODS AND SYSTEMS FOR GROWING PLANTS USING SILICATE-BASED SUBSTRATES, CULTIVATION OF ENHANCED PHOTOSYNTHETIC PRODUCTIVITY AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES FOR ENDOGENOUS GLYCOPYRANOSYL-PROTEIN DERIVATIVES, AND FORMULATIONS, PROCESSES AND SYSTEMS FOR THE SAME | Nonomura, Arthur M. (US) | 2014-10-01 | — | — | EP | disclosed |
| US-20140271474-A1 | INHIBITOR PROBES FOR IMAGING SODIUM-GLUCOSE COTRANSPORTERS IN HEALTH AND DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140235814-A1 | PREPARATION OF POLYURETHANES AND POLYESTERS FROM GLYCOLIPID TYPE COMPOUNDS | INSTITUT DES CORPS GRAS ETUDES ET RECHERCHES TECHNIQUES - ITERG (FR) | 2014-08-21 | — | — | US | disclosed |
| US-20140227218-A1 | Pharmaceutical Compositions of Conjugates Formed From Polymer Derivatives Having Particular Atom Arrangements | NEKTAR THERAPEUTICS (US) | 2014-08-14 | — | — | US | disclosed |
| EP-2764005-A1 | PREPARATION OF POLYURETHANES AND POLYESTERS FROM GLYCOLIPID TYPE COMPOUNDS | Université de Bordeaux (FR) | 2014-08-13 | — | — | EP | disclosed |
| EP-2755722-A2 | NOVEL SGLT INHIBITORS | Panacea Biotec Ltd. (IN) | 2014-07-23 | — | — | EP | disclosed |
| EP-2094292-B1 | NITRIC OXIDE-BLOCKED CROSS-LINKED TETRAMERIC HEMOGLOBIN | IKOR INC (US) | 2014-07-09 | — | — | EP | disclosed |
| US-20140128331-A1 | C-GLYCOSIDE DERIVATIVES | Xuanzhu Pharma Co., Ltd. (CN) | 2014-05-08 | — | — | US | disclosed |
| EP-2725031-A1 | C-GLYCOSIDE DERIVATIVES | Xuanzhu Pharma Co., Ltd. (CN) | 2014-04-30 | — | — | EP | disclosed |
| EP-2701514-A1 | MODIFICATION OF TREHALOSE-6-PHOSPHATE LEVELS IN PLANTS | Isis Innovation Limited (GB) | 2014-03-05 | — | — | EP | disclosed |
| US-8633277-B2 | Methods for forming polymer-drug conjugates | NEKTAR THERAPEUTICS (US) | 2014-01-21 | — | — | US | disclosed |
| US-8557182-B2 | Site selectively tagged and templated molecularly imprinted polymers for sensor applications | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2013-10-15 | — | — | US | disclosed |
| EP-2644206-A2 | PEG derivatives containing two PEG chains | Nektar Therapeutics (US) | 2013-10-02 | — | — | EP | disclosed |
| EP-2635685-A1 | METHOD FOR INCREASING YIELD AND FINE CHEMICAL PRODUCTION IN PLANTS | BASF Plant Science Company GmbH (DE) | 2013-09-11 | — | — | EP | disclosed |
| WO-2013078106-A1 | METHODS AND SYSTEMS FOR GROWING PLANTS USING SILICATE-BASED SUBSTRATES, CULTIVATION OF ENHANCED PHOTOSYNTHETIC PRODUCTIVITY AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES FOR ENDOGENOUS GLYCOPYRANOSYL-PROTEIN DERIVATIVES, AND FORMULATIONS, PROCESSES AND SYSTEMS FOR THE SAME | NONOMURA ARTHUR M (US) | 2013-05-30 | — | — | WO | disclosed |
| EP-2585541-A1 | SEMI-INTERPENETRATING POLYMER NETWORK | 3M Innovative Properties Company (US) | 2013-05-01 | — | — | EP | disclosed |
| US-20130090397-A1 | SEMI-INTERPENETRATING POLYMER NETWORK | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-04-11 | — | — | US | disclosed |
| WO-2013050377-A1 | PREPARATION OF POLYURETHANES AND POLYESTERS FROM GLYCOLIPID TYPE COMPOUNDS | UNIVERSITE DE BORDEAUX I (FR) | 2013-04-11 | — | — | WO | disclosed |
| WO-2013038429-A2 | NOVEL SGLT INHIBITORS | PANACEA BIOTEC LTD. (IN) | 2013-03-21 | — | — | WO | disclosed |
| US-20130064853-A1 | PARASITE VACCINE | MOREDUN RESEARCH INSTITUTE (GB) | 2013-03-14 | — | — | US | disclosed |
| US-8377717-B2 | Site selectively tagged and templated molecularly imprinted polymers for sensor applications | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2013-02-19 | — | — | US | disclosed |
| US-8360551-B2 | Ink-jet recording apparatus, recording method, and flushing method | SEIKO EPSON CORPORATION (JP) | 2013-01-29 | — | — | US | disclosed |
| US-8349906-B2 | Method of making macroporous cation exchange resins | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-01-08 | — | — | US | disclosed |
| WO-2012174285-A2 | INHIBITOR PROBES FOR IMAGING SODIUM-GLUCOSE COTRANSPORTERS IN HEALTH AND DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012146914-A1 | MODIFICATION OF TREHALOSE-6-PHOSPHATE LEVELS IN PLANTS | ISIS INNOVATION LIMITED (GB) | 2012-11-01 | — | — | WO | disclosed |
| US-20120270819-A1 | USE OF COMPOUNDS WITH SGLT-1/SGLT-2 INHIBITOR ACTIVITY FOR PRODUCING MEDICAMENTS FOR TREATMENT OF BONE DISEASE | SANOFI (FR) | 2012-10-25 | — | — | US | disclosed |
| EP-2512506-A2 | PARASITE VACCINE | Moredun Research Institute (GB) | 2012-10-24 | — | — | EP | disclosed |
| US-20120220529-A1 | NITRIC OXIDE-BLOCKED CROSS-LINKED TETRAMERIC HEMOGLOBIN | IKOR, INC. | 2012-08-30 | — | — | US | disclosed |
| EP-2482823-A2 | USE OF COMPOUNDS WITH SGLT-1/SGLT-2 INHIBITOR ACTIVITY FOR PRODUCING MEDICAMENTS FOR TREATMENT OF BONE DISEASES | SANOFI (FR) | 2012-08-08 | — | — | EP | disclosed |
| US-20120183504-A1 | COMPOSITION AND USE OF PROBIOTIC STRAIN GM-263 (ADR-1) IN TREATING RENAL FIBROSIS IN DIABETES | GENMONT BIOTECH INCORPORATION (TW) | 2012-07-19 | — | — | US | disclosed |
| WO-2012059849-A1 | METHOD FOR INCREASING YIELD AND FINE CHEMICAL PRODUCTION IN PLANTS | BASF PLANT SCIENCE COMPANY GMBH (DE) | 2012-05-10 | — | — | WO | disclosed |
| US-20120077679-A1 | Compositions And Methods For Anti-Transpiration In Plants | INNOVATION HAMMER, LLC | 2012-03-29 | — | — | US | disclosed |
| US-8129338-B2 | Nitric oxide-blocked cross-linked tetrameric hemoglobin | IKOR, INC. (US) | 2012-03-06 | — | — | US | disclosed |
| US-20120040419-A1 | METHOD FOR PRODUCING OIL BY CYSTOFILOBASIDIUM SPP. | FU-JEN CATHOLIC UNIVERSITY (TW) | 2012-02-16 | — | — | US | disclosed |
| US-8093182-B2 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC | 2012-01-10 | — | — | US | disclosed |
| WO-2011163070-A1 | SEMI-INTERPENETRATING POLYMER NETWORK | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-12-29 | — | — | WO | disclosed |
| US-20110178242-A1 | Methods for Forming Polymer-Drug Conjugates | NEKTAR THERAPEUTICS (US) | 2011-07-21 | — | — | US | disclosed |
| WO-2011073630-A2 | PARASITE VACCINE | MOREDUN RESEARCH INSTITUTE (GB) | 2011-06-23 | — | — | WO | disclosed |
| US-7947261-B2 | Moiety is positioned between a water-soluble polymer and a reactive group; water soluble polymer such as polyethylene glycol containing a urethane linkage moiety for example, and a reactive group for conjugating with biodrugs | NEKTAR THERAPEUTICS (US) | 2011-05-24 | — | — | US | disclosed |
| WO-2011039338-A2 | USE OF COMPOUNDS WITH SGLT-1/SGLT-2 INHIBITOR ACTIVITY FOR PRODUCING MEDICAMENTS FOR TREATMENT OF BONE DISEASES | SANOFI-AVENTIS (FR) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011041732-A2 | METHOD TO UPGRADE BIO-OILS TO FUEL AND BIO-CRUDE | MISSISSIPPI STATE UNIVERSITY (US) | 2011-04-07 | — | — | WO | disclosed |
| EP-2291189-A1 | METHOD FOR TREATING HYPERURICEMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME | Bristol-Myers Squibb Company (US) | 2011-03-09 | — | — | EP | disclosed |
| US-7887789-B2 | Polymer derivatives having particular atom arrangements | NEKTAR THERAPEUTICS (US) | 2011-02-15 | — | — | US | disclosed |
| US-20110012956-A1 | INK-JET RECORDING APPARATUS, RECORDING METHOD, AND FLUSHING METHOD | SEIKO EPSON CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| US-7820804-B2 | Fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof | Sanofi-Aventia Deutschland GmbH (DE) | 2010-10-26 | — | — | US | disclosed |
| US-20100233828-A1 | Site Selectively Tagged and Templated Molecularly Imprinted Polymers for Sensor Applications | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE (US) | 2010-09-16 | — | — | US | disclosed |
| US-20100116739-A1 | METHOD OF MAKING MACROPOROUS CATION EXCHANGE RESINS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-05-13 | — | — | US | disclosed |
| US-7674836-B2 | Method of making macroporous cation exchange resins | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-03-09 | — | — | US | disclosed |
| US-20100035797-A1 | Nitric oxide-blocked cross-linked tetrameric hemoglobin | IKOR Inc., a South Dakota Corporation | 2010-02-11 | — | — | US | disclosed |
| WO-2009143020-A1 | METHOD FOR TREATING HYPERURICEMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-11-26 | — | — | WO | disclosed |
| WO-2009143021-A1 | METHOD FOR TREATING AND PREVENTING KIDNEY STONES EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-11-26 | — | — | WO | disclosed |
| WO-2009143010-A1 | METHOD FOR TREATING HYPONATREMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-11-26 | — | — | WO | disclosed |
| EP-2094292-A2 | NITRIC OXIDE-BLOCKED CROSS-LINKED TETRAMERIC HEMOGLOBIN | Ikor, Inc. (US) | 2009-09-02 | — | — | EP | disclosed |
| EP-2046877-A1 | METHOD OF MAKING MACROPOROUS CATION EXCHANGE RESINS | 3M Innovative Properties Company (US) | 2009-04-15 | — | — | EP | disclosed |
| US-7504377-B2 | Nitric oxide-blocked cross-linked tetrameric hemoglobin | IKOR, INC. (US) | 2009-03-17 | — | — | US | disclosed |
| US-7494974-B2 | Carboxymethylated cross-linked tetrameric hemoglobin | IKOR, INC. (US) | 2009-02-24 | — | — | US | disclosed |
| EP-1991689-A1 | PROCESS FOR THE PRODUCTION OF A FINE CHEMICAL | Metanomics GmbH (DE) | 2008-11-19 | — | — | EP | disclosed |
| WO-2008051689-A2 | NITRIC OXIDE-BLOCKED CROSS-LINKED TETRAMERIC HEMOGLOBIN | IKOR, INC. (US) | 2008-05-02 | — | — | WO | disclosed |
| WO-2008046664-A1 | METHOD AND DEVICE FOR THE SELECTIVE ISOLATION OF SEROTYPES OF SHIGA TOXIN PRODUCING E. COLI | UNIVERSITEIT GENT (BE) | 2008-04-24 | — | — | WO | disclosed |
| US-20080096805-A1 | deoxygenated, endotoxin-free and stroma-free transport proteins, incapable of binding with nitric oxide, useful as substitutes for erythrocytes in mammals and for treating disorders where oxygen delivery agents are of benefit | IKOR, INC. | 2008-04-24 | — | — | US | disclosed |
| US-20080096803-A1 | Carboxymethylated cross-linked tetrameric hemoglobin | IKOR, INC. | 2008-04-24 | — | — | US | disclosed |
| WO-2008034648-A1 | PROCESS FOR THE PRODUCTION OF A FINE CHEMICAL | METANOMICS GMBH (DE) | 2008-03-27 | — | — | WO | disclosed |
| US-20080027153-A1 | METHOD OF MAKING MACROPOROUS CATION EXCHANGE RESINS | 3M INNOVATIVE PROPERTIES COMPANY | 2008-01-31 | — | — | US | disclosed |
| WO-2008014137-A1 | METHOD OF MAKING MACROPOROUS CATION EXCHANGE RESINS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-01-31 | — | — | WO | disclosed |
| EP-1448785-B1 | ENZYMATIC SYNTHESIS OF SUGAR ACRYLATES | BASF AG (DE) | 2007-10-03 | — | — | EP | disclosed |
| US-20070197623-A1 | NOVEL FLUOROGLYCOSIDE DERIVATIVES OF PYRAZOLES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THE USE THEREOF | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-08-23 | — | — | US | disclosed |
| US-20070141712-A1 | Method for analysing metabolites | MAX-PLANCK-GESSELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2007-06-21 | — | — | US | disclosed |
| US-20070135543-A1 | Hot melt adhesive composition | JSR CORPORATION (JP) | 2007-06-14 | — | — | US | disclosed |
| EP-1444522-B1 | SCREENING FOR ANTIVIRAL AGENTS AFFECTING SIGNAL PEPTIDASE | MEDICAL RES COUNCIL (GB) | 2007-01-03 | — | — | EP | disclosed |
| US-20060275252-A1 | Conjugates formed from polymer derivatives having particular atom arrangements | NEKTAR THERAPEUTICS | 2006-12-07 | — | — | US | disclosed |
| US-7138035-B2 | Process for the selective modification of carbohydrates by peroxidase catalyzed oxidation | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2006-11-21 | — | — | US | disclosed |
| EP-1711834-A2 | PROCESS FOR SCREENING GLYCOFORM-SPECIFIC ANTIBODIES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2006-10-18 | — | — | EP | disclosed |
| EP-1700896-A1 | HOT MELT ADHESIVE COMPOSITION | JSR Corporation (JP) | 2006-09-13 | — | — | EP | disclosed |
| EP-1699807-A2 | GLUCOPYRANOSYLOXY-SUBSTITUTED AROMATES, MEDICAMENTS CONTAINING SAID COMPOUNDS, THE USE THEREOF, AND METHODS FOR PRODUCING THE SAME | Boehringer Ingelheim International GmbH (DE) | 2006-09-13 | — | — | EP | disclosed |
| EP-1695088-A1 | METHOD FOR ANALYSING METABOLITES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2006-08-30 | — | — | EP | disclosed |
| EP-1687037-A1 | GENTLE AND ENHANCED PRESERVATIVE SYSTEMS | BAUSCH & LOMB INCORPORATED (US) | 2006-08-09 | — | — | EP | disclosed |
| US-20060142158-A1 | Compositions and methods for anti-transpiration in plants | INNOVATION HAMMER, LLC | 2006-06-29 | — | — | US | disclosed |
| EP-1660509-A2 | GLUCOPYRANOSYLOXY- PIRAZOLES, DRUGS CONTAINING SAID COMPOUNDS THE USE AND PRODUCTION METHOD THEREOF | Boehringer Ingelheim International GmbH (DE) | 2006-05-31 | — | — | EP | disclosed |
| EP-1626741-A2 | PEG DERIVATIVES HAVING AN AMIDOCARBONATE LINKAGE | Nektar Therapeutics Al, Corporation (US) | 2006-02-22 | — | — | EP | disclosed |
| EP-1173409-B8 | OXIDISED CARBOHYDRATES | TNO (NL) | 2006-01-11 | — | — | EP | disclosed |
| EP-1173409-B1 | OXIDISED CARBOHYDRATES | SCA HYGIENE PROD ZEIST BV (NL) | 2005-11-02 | — | — | EP | disclosed |
| US-20050227258-A1 | Site selectively tagged and templated molecularly imprinted polymers for sensor applications | NATIONAL SCIENCE FOUNDATION | 2005-10-13 | — | — | US | disclosed |
| WO-2005076013-A2 | PROCESS FOR SCREENING GLYCOFORM-SPECIFIC ANTIBODIES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-08-18 | — | — | WO | disclosed |
| US-20050181007-A1 | Soft tissue implants and anti-scarring agents | ANGIOTECH INTERNATIONAL AG (CH) | 2005-08-18 | — | — | US | disclosed |
| WO-2005063785-A2 | GLUCOPYRANOSYLOXY-SUBSTITUTED AROMATES, MEDICAMENTS CONTAINING SAID COMPOUNDS, THE USE THEREOF, AND METHODS FOR PRODUCING THE SAME | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-07-14 | — | — | WO | disclosed |
| WO-2005059556-A1 | METHOD FOR ANALYSING METABOLITES | MAX PLANCK GESELLLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2005-06-30 | — | — | WO | disclosed |
| WO-2005053758-A1 | GENTLE AND ENHANCED PRESERVATIVE SYSTEMS | BAUSCH & LOMB INCORPORATED (US) | 2005-06-16 | — | — | WO | disclosed |
| US-20050089839-A1 | Assay | MEDICAL RESEARCH COUNCIL (GB) | 2005-04-28 | — | — | US | disclosed |
| US-6875861-B1 | Process for producing nitrosonium ions | SCA HYGIENE PRODUCTS ZEIST B.V. (NL) | 2005-04-05 | — | — | US | disclosed |
| US-20050055748-A1 | Stress-responsive genes, regulatory elements, and methods of use for same | PIONEER HI-BRED INTERNATIONAL, INC. | 2005-03-10 | — | — | US | disclosed |
| WO-2005021566-A2 | GLUCOPYRANOSYLOXY- PIRAZOLES, DRUGS CONTAINING SAID COMPOUNDS THE USE AND PRODUCTION METHOD THEREOF | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-03-10 | — | — | WO | disclosed |
| US-20050009988-A1 | Polymer derivatives having particular atom arrangements | NEKTAR THERAPEUTICS | 2005-01-13 | — | — | US | disclosed |
| WO-2005000360-A2 | PEG DERIVATIVES HAVING AN AMIDOCARBONATE LINKAGE | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2005-01-06 | — | — | WO | disclosed |
| US-20040241763-A1 | Method for diagnosing multiple sclerosis | GLYCOMINDS LTD (IL) | 2004-12-02 | — | — | US | disclosed |
| EP-1448785-A2 | ENZYMATIC SYNTHESIS OF SUGAR ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-25 | — | — | EP | disclosed |
| EP-1009426-A4 | METHOD FOR TREATING A SUBJECT SUFFERING FROM CONDITIONS ASSOCIATED WITH AN EXTRACELLULAR ZINC SPHINGOMYELINASE | UNIV COLUMBIA (US) | 2004-08-25 | — | — | EP | disclosed |
| EP-1444522-A2 | SCREENING FOR ANTIVIRAL AGENTS AFFECTING SIGNAL PEPTIDASE | MEDICAL RESEARCH COUNCIL (GB) | 2004-08-11 | — | — | EP | disclosed |
| EP-1122275-B1 | Aliphatic polyester, method for manufacturing aliphatic polyester, and method for recycling cellulose | CANON KK (JP) | 2004-06-02 | — | — | EP | disclosed |
| US-20040047851-A1 | Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase | THE TRUSTEES OF COLUMBIA UNIVERSITY | 2004-03-11 | — | — | US | disclosed |
| US-20040040472-A1 | Method of recycling cement kiln dust | PNC BANK, NATIONAL ASSOCIATION | 2004-03-04 | — | — | US | disclosed |
| US-20040040472-A1 | Method of recycling cement kiln dust | PNC BANK, NATIONAL ASSOCIATION | 2004-03-04 | — | — | US | disclosed |
| US-20040023361-A1 | Lactic acid bacteria producing polysaccharide similar to those in human milk and corresponding gene | NESTEC S.A. | 2004-02-05 | — | — | US | disclosed |
| EP-1353750-A1 | STABLE FREE NITROXYL RADICALS AS OXIDATION CATALYSTS AND PROCESS FOR OXIDATION | Ciba SC Holding AG (CH) | 2003-10-22 | — | — | EP | disclosed |
| US-6613322-B2 | Administering enzyme inhibitors | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2003-09-02 | — | — | US | disclosed |
| WO-2003042227-A2 | ENZYMATIC SYNTHESIS OF SUGAR ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-22 | — | — | WO | disclosed |
| WO-2003040684-A2 | SCREENING FOR ANTIVIRAL AFFECTING SIGNAL PEPTIDASE | MEDICAL RESEARCH COUNCIL (GB) | 2003-05-15 | — | — | WO | disclosed |
| EP-1290213-A2 | ASSAY FOR KINASES AND PHOSPHATASES | PROMEGA CORPORATION (US) | 2003-03-12 | — | — | EP | disclosed |
| JP-2003055009-A | FLOWABLE SLURRY, PROCESS FOR PREPARING THE SAME, AND PROCESS FOR MANUFACTURE OF PORTLAND CEMENT | DOW CORNING CORP | 2003-02-26 | — | — | JP | disclosed |
| US-20030029588-A1 | Process for the selective modification of carbohydrates by peroxidase catalyzed oxidation | BRUNOB II B.V. (NL) | 2003-02-13 | — | — | US | disclosed |
| US-20030026796-A1 | Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-02-06 | — | — | US | disclosed |
| EP-1277710-A1 | Process for preparing a flowable slurry | DOW CORNING CORPORATION (US) | 2003-01-22 | — | — | EP | disclosed |
| EP-1277710-A1 | Process for preparing a flowable slurry | DOW CORNING CORPORATION (US) | 2003-01-22 | — | — | EP | disclosed |
| US-6478870-B2 | CEMENTS | DOW CORNING CORPORATION | 2002-11-12 | — | — | US | disclosed |
| US-6478870-B2 | CEMENTS | DOW CORNING CORPORATION | 2002-11-12 | — | — | US | disclosed |
| WO-2002058844-A1 | STABLE FREE NITROXYL RADICALS AS OXIDATION CATALYSTS AND PROCESS FOR OXIDATION | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-08-01 | — | — | WO | disclosed |
| US-6420513-B2 | HYDROLYSIS OF CELLULOSE FORMING GLUCOSE; CYCLIZATION TO GLUCONOLACTONE; METATHESIS RING-OPENING POLYMERIZATION | CANON KABUSHIKI KAISHA (JP) | 2002-07-16 | — | — | US | disclosed |
| US-6413521-B1 | Helminth parasite antigen with aminopeptidase-like activity | THE BARBRAHAM INSTITUTE (GB) | 2002-07-02 | — | — | US | disclosed |
| US-20020033121-A1 | Process aid for preparing a flowable slurry | DOW CORNING CORPORATION | 2002-03-21 | — | — | US | disclosed |
| US-20020033121-A1 | Process aid for preparing a flowable slurry | DOW CORNING CORPORATION | 2002-03-21 | — | — | US | disclosed |
| US-6346182-B1 | PLACING CONDUCTIVE PARTICULATE SUBSTRATE AND CATALYST SOURCE INTO ELECTRICALLY CONDUCTIVE ENVIRONMENT, ALIGNING SUBSTRATE WITH ELECTRIC FIELD, CREATING ELECTRIC FIELD SUFFICIENT TO DEPOSIT CATALYST ON SUBSTRATE AT PREDETERMINED LOCATION | DREXEL UNIVERSITY | 2002-02-12 | — | — | US | disclosed |
| EP-1173409-A1 | PROCESS FOR PRODUCING NITROSONIUM IONS | SCA Hygiene Products Zeist B.V. (NL) | 2002-01-23 | — | — | EP | disclosed |
| WO-2000017103-A9 | INVENTORY CONTROL | MASSACHUSETTS INST TECHNOLOGY (US) | 2001-12-20 | — | — | WO | disclosed |
| WO-2001092560-A2 | ASSAY FOR KINASES AND PHOSPHATASES | PROMEGA CORPORATION (US) | 2001-12-06 | — | — | WO | disclosed |
| EP-0983511-A4 | SENSORS FOR SUGARS AND OTHER METAL BINDING ANALYTES | CALIFORNIA INST OF TECHN (US) | 2001-12-05 | — | — | EP | disclosed |
| US-20010039327-A1 | Aliphatic polyester, method for manufacturing aliphatic polyester, and method for recycling cellulose | CANON KABUSHIKI KAISHA (JP) | 2001-11-08 | — | — | US | disclosed |
| US-6306445-B1 | INORPORATING INTO THE DOUGH AN EFFECTIVE AMOUNT OF ONE OR MORE DEHYDROGENASES COMPRISING NAD(P)-INDEPENDENT DEHYDROGENASE AND NAD(P)-DEPENDENT DEHYDROGENASE | NOVOZYMES BIOTECH INC. | 2001-10-23 | — | — | US | disclosed |
| WO-2000017655-A9 | WATER-SOLUBLE FLUORESCENT SEMICONDUCTOR NANOCRYSTALS | MASSACHUSETTS INST TECHNOLOGY (US) | 2001-10-04 | — | — | WO | disclosed |
| EP-1122275-A2 | Aliphatic polyester, method for manufacturing aliphatic polyester, and method for recycling cellulose | CANON KABUSHIKI KAISHA (JP) | 2001-08-08 | — | — | EP | disclosed |
| WO-2001037804-A2 | PRESERVATION AND FORMULATION OF BIOACTIVE MATERIALS | UNIVERSAL PRESERVATION TECHNOLOGIES, INC. (US) | 2001-05-31 | — | — | WO | disclosed |
| EP-1086225-A2 | HUMAN TUMOUR-DERIVED POLYPEPTIDE HORMONE PHOSPHATONIN | UNIVERSITY COLLEGE LONDON (GB) | 2001-03-28 | — | — | EP | disclosed |
| EP-1077609-A1 | METHODS FOR USING DEHYDROGENASES IN BAKING | NOVO NORDISK BIOTECH, INC. (US) | 2001-02-28 | — | — | EP | disclosed |
| EP-1071500-A1 | SMALL DENSE MICROPOROUS SOLID SUPPORT MATERIALS, THEIR PREPARATION, AND USE FOR PURIFICATION OF LARGE MACROMOLECULES AND BIOPARTICLES | Life Technologies, Inc. (US) | 2001-01-31 | — | — | EP | disclosed |
| WO-2001000681-A1 | PROCESS FOR SELECTIVE OXIDATION OF PRIMARY ALCOHOLS | SCA HYGIENE PRODUCTS ZEIST B.V. (NL) | 2001-01-04 | — | — | WO | disclosed |
| WO-2000050388-A1 | PROCESS FOR PRODUCING NITROSONIUM IONS | SCA HYGIENE PRODUCTS ZEIST B.V. (NL) | 2000-08-31 | — | — | WO | disclosed |
| WO-2000043465-A1 | WATER BASED DEEP WATER DRILLING FLUID | KENNEY NORMAN P (US) | 2000-07-27 | — | — | WO | disclosed |
| EP-1009426-A1 | METHOD FOR TREATING A SUBJECT SUFFERING FROM CONDITIONS ASSOCIATED WITH AN EXTRACELLULAR ZINC SPHINGOMYELINASE | The Trustees of Columbia University in the City of New York (US) | 2000-06-21 | — | — | EP | disclosed |
| EP-0983511-A1 | SENSORS FOR SUGARS AND OTHER METAL BINDING ANALYTES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-03-08 | — | — | EP | disclosed |
| EP-0977766-A1 | GLYCOCONJUGATED FLUORESCENT LABELING REAGENTS | CARNEGIE-MELLON UNIVERSITY (US) | 2000-02-09 | — | — | EP | disclosed |
| US-6004759-A | TESTING FOR THE PRESENCE OF AN AUTOIMMUNE IMMUNOGLOBULIN IN A SUSPECTED PATIENT'S SERUM WHEREIN THE IMMUNOGLOBULIN IS IDENTIFIED BY ITS ABILITY TO INTERFERE WITH THE GLUCOSE TRANSPORTING ACTIVITY OF A PANCREATIC ISLET CELL GLUCOSE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-12-21 | — | — | US | disclosed |
| WO-1999060017-A2 | HUMAN TUMOUR-DERIVED POLYPEPTIDE HORMONE PHOSPHATONIN | UNIVERSITY COLLEGE LONDON (GB) | 1999-11-25 | — | — | WO | disclosed |
| US-5989882-A | DNA SEQUENCE ENCODING AN ENZYME FROM ACTINOMYCETES; ANTIDIABETIC AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-11-23 | — | — | US | disclosed |
| WO-1999057986-A1 | METHODS FOR USING DEHYDROGENASES IN BAKING | NOVO NORDISK BIOTECH, INC. (US) | 1999-11-18 | — | — | WO | disclosed |
| US-5981743-A | Cyclic ester ring-opened oligomers and methods of preparation | UNIVERSITY OF MASSACHUSETTS (US) | 1999-11-09 | — | — | US | disclosed |
| WO-1999051316-A1 | SMALL DENSE MICROPOROUS SOLID SUPPORT MATERIALS, THEIR PREPARATION, AND USE FOR PURIFICATION OF LARGE MACROMOLECULES AND BIOPARTICLES | LIFE TECHNOLOGIES, INC. (US) | 1999-10-14 | — | — | WO | disclosed |
| WO-1999047258-A1 | CATALYTIC MATERIALS FOR SELECTIVE OXIDATION OF ALCOHOLS, PROCESS FOR PRODUCTION THEREOF AND THEIR USE IN ALCOHOL OXIDATION PROCESS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1999-09-23 | — | — | WO | disclosed |
| EP-0566666-B1 | NOVEL GLUCOHYDROLASE INHIBITORS USEFUL AS ANTIDIABETIC ANTIVITAL AND ANTIMETASTATIC AGENTS | MERRELL PHARMA INC (US) | 1999-08-11 | — | — | EP | disclosed |
| WO-1999024030-A1 | NOVEL TRIENYL COMPOUNDS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1999-05-20 | — | — | WO | disclosed |
| WO-1999011283-A1 | METHOD FOR TREATING A SUBJECT SUFFERING FROM CONDITIONS ASSOCIATED WITH AN EXTRACELLULAR ZINC SPHINGOMYELINASE | THE TRUSTEES OF COLOMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1999-03-11 | — | — | WO | disclosed |
| US-5877310-A | INCUBATING A TARGET MATERIAL HAVING A FUNCTIONAL GROUP AND A GLYCOCONJUGATED FLUORESCENT COMPOUND OF A FLUOROPHORE,A SUGAR AND A REACTIVE GROUP FOR A PERIOD OF TIME SUFFICIENT TO REACT REACTIVE GROUP WITH FUNCTIONAL GROUP OF THE TARGET | CARNEGIE MELLON UNIVERSITY (US) | 1999-03-02 | — | — | US | disclosed |
| WO-1998049176-A1 | GLYCOCONJUGATED FLUORESCENT LABELING REAGENTS | CARNEGIE MELLON UNIVERSITY (US) | 1998-11-05 | — | — | WO | disclosed |
| EP-0846760-A1 | Production and use of anthelmintic agents and protective immunogens | THE BABRAHAM INSTITUTE (GB) | 1998-06-10 | — | — | EP | disclosed |
| EP-0463053-B1 | PRODUCTION AND USE OF ANTHELMINTIC AGENTS AND PROTECTIVE IMMUNOGENS | BABRAHAM INST (GB) | 1998-05-20 | — | — | EP | disclosed |
| US-5747046-A | ANTIBODIES AND PROTEIN COMPLEXES AS NEMATOCIDES | MUNN EDWARD ALBERT (GB) | 1998-05-05 | — | — | US | disclosed |
| EP-0458847-B1 | A PROCESS FOR PRODUCING GLYCOSIDE ESTERS AND COMPOSITIONS COMPRISING GLYCOSIDE ESTERS | NOVO NORDISK AS (DK) | 1997-11-19 | — | — | EP | disclosed |
| WO-1997039626-A1 | PESTICIDES TRAPPED IN EMULSIFIABLE GRANULES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-10-30 | — | — | WO | disclosed |
| EP-0796915-A2 | Process for the preparation and use of acarviosyl-transferase in the conversion of ascarbose-homologous in acarbose and in the preparation of acarbose-homologous | BAYER AG (DE) | 1997-09-24 | — | — | EP | disclosed |
| WO-1997033177-A1 | SENSORS FOR SUGARS AND OTHER METAL BINDING ANALYTES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1997-09-12 | — | — | WO | disclosed |
| WO-1997005489-A1 | SOLUBLE AND POLYMERIC METAL COMPLEXING MATERIALS FOR MEASUREMENT OF SUGARS AND RELATED MOLECULES IN SOLUTION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1997-02-13 | — | — | WO | disclosed |
| US-5563251-A | Process for making surfactants | CONDEA VISTA COMPANY (US) | 1996-10-08 | — | — | US | disclosed |
| EP-0550067-B1 | High load spray dry encapsulation | HERCULES INC (US) | 1996-09-18 | — | — | EP | disclosed |
| EP-0726950-A1 | HELMINTH PARASITE ANTIGEN WITH AMINOPEPTIDASE-LIKE ACTIVITY | THE BABRAHAM INSTITUTE (GB) | 1996-08-21 | — | — | EP | disclosed |
| WO-1996020236-A1 | POLYGLYCOMERS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1996-07-04 | — | — | WO | disclosed |
| US-5438069-A | Glucohydrolase inhibitors useful as antidiabetic agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-08-01 | — | — | US | disclosed |
| WO-1995012671-A1 | HELMINTH PARASITE ANTIGEN WITH AMINOPEPTIDASE-LIKE ACTIVITY | BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL (GB) | 1995-05-11 | — | — | WO | disclosed |
| US-5387700-A | Reacting alcohol with sulfuryl chloride in toluene in presence of pyridine or triethylamine to form chlorosulfate, reacting with ammonia or amine in tetrahydrofuran to produce sulfamate | MCNEILAB, INC. (US) | 1995-02-07 | — | — | US | disclosed |
| EP-0550067-A1 | High load spray dry encapsulation | HERCULES INCORPORATED (US) | 1993-07-07 | — | — | EP | disclosed |
| US-5200328-A | Reacting a fatty acid or ester with a methyl glycoside in the presence of immobilized lipase | NOVO NORDISK A/S (DK) | 1993-04-06 | — | — | US | disclosed |
| EP-0528624-A1 | Di and Tri saccharides, methods of making them and hair growth compositions containing them | UNILEVER PLC (GB) | 1993-02-24 | — | — | EP | disclosed |
| US-5175085-A | Testing immunoglobins in patient's serum | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-12-29 | — | — | US | disclosed |
| EP-0497904-A4 | COMPOSITIONS CONTAINING PLANT-PRODUCED GLYCOPOLYPEPTIDE MULTIMERS, MULTIMERIC PROTEINS, AND THEIR USE | — | 1992-12-09 | — | — | EP | disclosed |
| EP-0497904-A1 | COMPOSITIONS CONTAINING PLANT-PRODUCED GLYCOPOLYPEPTIDE MULTIMERS AND METHODS FOR THEIR PRODUCTION | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1992-08-12 | — | — | EP | disclosed |
| WO-1992011867-A1 | NOVEL GLUCOHYDROLASE INHIBITORS USEFUL AS ANTIDIABETIC AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-07-23 | — | — | WO | disclosed |
| EP-0463053-A1 | PRODUCTION AND USE OF ANTHELMINTIC AGENTS AND PROTECTIVE IMMUNOGENS | THE BABRAHAM INSTITUTE (GB) | 1992-01-02 | — | — | EP | disclosed |
| EP-0458847-A1 | A PROCESS FOR PRODUCING GLYCOSIDE ESTERS AND COMPOSITIONS COMPRISING GLYCOSIDE ESTERS | NOVO NORDISK A/S (DK) | 1991-12-04 | — | — | EP | disclosed |
| EP-0445914-A1 | Carrier composition and method | HERCULES INCORPORATED (US) | 1991-09-11 | — | — | EP | disclosed |
| WO-1991013361-A1 | METHODS AND COMPOSITIONS FOR DIAGNOSING AUTOIMMUNE INSULIN DEPENDENT DIABETES MELLITUS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-09-05 | — | — | WO | disclosed |
| WO-1991006320-A1 | COMPOSITIONS CONTAINING PLANT-PRODUCED GLYCOPOLYPEPTIDE MULTIMERS, MULTIMERIC PROTEINS, AND THEIR USE | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1991-05-16 | — | — | WO | disclosed |
| EP-0153501-B1 | NOVEL SYNTHETIC HOMO- AND HETEROPOLYSACCHARIDES AND A METHOD FOR THE PREPARATION THEREOF | National Starch and Chemical Investment Holding Corporation (US) | 1991-04-10 | — | — | EP | disclosed |
| WO-1990011086-A1 | PRODUCTION AND USE OF ANTHELMINTIC AGENTS AND PROTECTIVE IMMUNOGENS | MUNN EDWARD ALBERT (GB) | 1990-10-04 | — | — | WO | disclosed |
| WO-1990009451-A1 | A PROCESS FOR PRODUCING GLYCOSIDE ESTERS AND COMPOSITIONS COMPRISING GLYCOSIDE ESTERS | NOVO NORDISK A/S (DK) | 1990-08-23 | — | — | WO | disclosed |
| EP-0320267-A2 | Glycoprotein growth modulation materials | ALLIANCE PHARMACEUTICAL CORPORATION (US) | 1989-06-14 | — | — | EP | disclosed |
| EP-0173668-B1 | RECOMBINANT SACCHAROMYCES | SMITHKLINE BEECHAM CORPORATION (US) | 1989-05-31 | — | — | EP | disclosed |
| US-4831128-A | Synthetic homo- and heteropolysaccharides and a method for the preparation thereof | NATIONAL STARCH AND CHEMICAL CORPORATION (US) | 1989-05-16 | — | — | US | disclosed |
| EP-0192296-B1 | NOVEL DISACCHARIDE AND TRISACCHARIDE DERIVATIVES OF THE \"LIPID A\" TYPE | AKZO N.V. (NL) | 1988-12-28 | — | — | EP | disclosed |
| EP-0187798-B1 | PROCESS FOR THE SYNTHESIS OF ALDOSIDES OR OLIGOALDOSIDES OF ALKYL, CYCLOALKYL OR ALKENYL | BEGHIN-SAY SOCIETE ANONYME (FR) | 1988-11-30 | — | — | EP | disclosed |
| US-4739043-A | REACTING AN ALCOHOL WITH AND ALDOSE IN HYDROGEN FLUORIDE SOLVENT | BEGHIN-SAY, S.A. (FR) | 1988-04-19 | — | — | US | disclosed |
| US-4719202-A | Disaccharide and trisaccharide derivatives of the \"Lipid A\" type | AKZO N.V. (NL) | 1988-01-12 | — | — | US | disclosed |
| EP-0192296-A1 | Novel disaccharide and trisaccharide derivatives of the \"Lipid A\" type | AKZO N.V. (NL) | 1986-08-27 | — | — | EP | disclosed |
| EP-0187798-A1 | PROCESS FOR THE SYNTHESIS OF ALDOSIDES OR OLIGOALDOSIDES OF ALKYL, CYCLOALKYL OR ALKENYL. | BEGHIN SAY SA (FR) | 1986-07-23 | — | — | EP | disclosed |
| EP-0035589-B1 | CONTINUOUS PROCESS FOR PRODUCING METHYL GLUCOSIDES FROM STARCH | A.E. STALEY MANUFACTURING COMPANY (US) | 1986-03-05 | — | — | EP | disclosed |
| WO-1986000906-A1 | PROCESS FOR THE SYNTHESIS OF ALDOSIDES OR POLYALDOSIDES OF ALKYL, CYCLOALKYL OR ALKENYL | BEGHIN-SAY SA (FR) | 1986-02-13 | — | — | WO | disclosed |
| EP-0153501-A2 | Novel synthetic homo- and heteropolysaccharides and a method for the preparation thereof | National Starch and Chemical Investment Holding Corporation (US) | 1985-09-04 | — | — | EP | disclosed |
| US-4329449-A | Method of using recycled mother liquors to produce aldosides | A. E. STALEY MANUFACTURING COMPANY (US) | 1982-05-11 | — | — | US | disclosed |
| EP-0035589-A1 | Continuous process for producing methyl glucosides from starch | A.E. STALEY MANUFACTURING COMPANY (US) | 1981-09-16 | — | — | EP | disclosed |
| EP-0031005-A1 | Process for preparing coherent hydrosoluble polymers | RÖHM GMBH (DE) | 1981-07-01 | — | — | EP | disclosed |
| EP-0021339-A1 | Sugar esters and glycosides, their preparation and pharmaceutical compositions containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-01-07 | — | — | EP | disclosed |
| US-3971852-A | Process of encapsulating an oil and product produced thereby | POLAK'S FRUTAL WORKS, INC. (US) | 1976-07-27 | — | — | US | disclosed |
| US-3971852-A | Process of encapsulating an oil and product produced thereby | POLAK'S FRUTAL WORKS, INC. (US) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (32 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190055226-A1 | 5-FLUORO-C-(ARYL OR HETEROCYCLYL)-GLYCOSIDE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS | SLC5A2, SLC5A1, SLC2A2 | PYGB 726/4885LGALS8 179/4885LGALS1 186/4885 |
| US-10696662-B2 | 5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators | SLC5A2, SLC5A1, SLC2A2 | PYGB 726/4885LGALS8 179/4885LGALS1 186/4885 |
| US-20050181007-A1 | Soft tissue implants and anti-scarring agents | MMP1, COL2A1, FN1 | PYGB 1092/4885LGALS8 138/4885LGALS1 127/4885 |
| US-20260062633-A1 | EMULSION | C5, PHOSPHO1, PFKFB1 | PYGB 1180/4885LGALS8 1472/4885LGALS1 832/4885 |
| US-20040023361-A1 | Lactic acid bacteria producing polysaccharide similar to those in human milk and corresponding gene | RPS6, MGAM, MIF | PYGB 1080/4885LGALS8 384/4885LGALS1 574/4885 |
| US-20150191502-A1 | OPTICALLY PURE BENZYL-4-CHLOROPHENYL-C-GLUCOSIDE DERIVATIVE | SLC5A2, SLC5A1, GCG | PYGB 168/4885LGALS8 1273/4885LGALS1 1089/4885 |
| US-20050009988-A1 | Polymer derivatives having particular atom arrangements | CD44, PIGO, PGLS | PYGB 295/4885LGALS8 779/4885LGALS1 1455/4885 |
| US-20140227218-A1 | Pharmaceutical Compositions of Conjugates Formed From Polymer Derivatives Having Particular Atom Arrangements | PAICS, UGT2B7, LPXN | PYGB 158/4885LGALS8 1605/4885LGALS1 2866/4885 |
| US-20190022236-A1 | POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS | CD44, PIGO, PGLS | PYGB 295/4885LGALS8 779/4885LGALS1 1455/4885 |
| US-20140271474-A1 | INHIBITOR PROBES FOR IMAGING SODIUM-GLUCOSE COTRANSPORTERS IN HEALTH AND DISEASE | SLC5A1, SLC5A2, SLC2A4 | PYGB 171/4885LGALS8 237/4885LGALS1 149/4885 |
| US-20140128331-A1 | C-GLYCOSIDE DERIVATIVES | RDX, C3AR1, C1R | PYGB 864/4885LGALS8 868/4885LGALS1 707/4885 |
| US-20200291004-A1 | 5-FLUORO-C-(ARYL OR HETEROCYCLYL)-GLYCOSIDE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS | SLC5A2, SLC5A1, SLC2A2 | PYGB 698/4885LGALS8 186/4885LGALS1 200/4885 |
| US-11446385-B2 | Polymer derivatives having particular atom arrangements | CD44, PIGO, PGLS | PYGB 295/4885LGALS8 779/4885LGALS1 1455/4885 |
| US-20160194264-A1 | OPTICALLY PURE BENZYL-4-CHLOROPHENYL-C-GLUCOSIDE DERIVATIVE | SLC5A2, SLC5A1, GCG | PYGB 168/4885LGALS8 1273/4885LGALS1 1089/4885 |
| US-20150328331-A1 | Compositions Comprising a Polymeric Reagent and a Pharmacologically Active Agent | PHOSPHO1, PAICS, FCGRT | PYGB 207/4885LGALS8 359/4885LGALS1 532/4885 |
| US-20210388016-A1 | GLUCOPYRANOSE DERIVATIVES USEFUL AS SGLT2 INHIBITORS | SLC5A2, SLC5A1, UGGT1 | PYGB 262/4885LGALS8 224/4885LGALS1 124/4885 |
| US-20180118884-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | ALG1, CSGALNACT1, ALG8 | PYGB 242/4885LGALS8 199/4885LGALS1 139/4885 |
| US-11014917-B2 | 5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators | SLC5A2, SLC5A1, SLC2A2 | PYGB 698/4885LGALS8 186/4885LGALS1 200/4885 |
| US-10815210-B2 | Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators | SLC5A2, SLC5A1, SLC2A2 | PYGB 606/4885LGALS8 752/4885LGALS1 544/4885 |
| US-20230113413-A1 | POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS | CD44, PIGO, PGLS | PYGB 295/4885LGALS8 779/4885LGALS1 1455/4885 |
| US-10646578-B2 | Polymer derivatives having particular atom arrangements | CD44, PIGO, PGLS | PYGB 295/4885LGALS8 779/4885LGALS1 1455/4885 |
| US-20210238170-A1 | 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators | SLC5A2, SLC5A1, SLC2A4 | PYGB 343/4885LGALS8 214/4885LGALS1 226/4885 |
| US-20160324974-A1 | METHOD FOR PREPARING A POLYMERIC REAGENT | SI, PAICS, DNPEP | PYGB 546/4885LGALS8 780/4885LGALS1 1395/4885 |
| US-20210388015-A1 | GLUCOPYRANOSE DERIVATIVES USEFUL AS SGLT2 INHIBITORS | SLC5A2, SLC5A1, UGGT1 | PYGB 262/4885LGALS8 224/4885LGALS1 124/4885 |
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | PYGB 283/4885LGALS8 61/4885LGALS1 50/4885 |
| US-20200246471-A1 | POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS | CD44, PIGO, PGLS | PYGB 295/4885LGALS8 779/4885LGALS1 1455/4885 |
| US-20060275252-A1 | Conjugates formed from polymer derivatives having particular atom arrangements | CD44, PAICS, PIGO | PYGB 592/4885LGALS8 1297/4885LGALS1 2102/4885 |
| US-20120270819-A1 | USE OF COMPOUNDS WITH SGLT-1/SGLT-2 INHIBITOR ACTIVITY FOR PRODUCING MEDICAMENTS FOR TREATMENT OF BONE DISEASE | SLC5A1, SLC5A2, SOST | PYGB 1473/4885LGALS8 407/4885LGALS1 75/4885 |
| US-20260130973-A1 | COMPOSITIONS AND METHODS FOR DEGRADATION OF LIPOFUSCIN CYCLORETINAL BY MSP1 | SCAMP2, LAMP1, LAMP2 | PYGB 3584/4885LGALS8 1801/4885LGALS1 465/4885 |
| US-10253010-B2 | C-glycoside derivative | RDX, C1R, C3AR1 | PYGB 822/4885LGALS8 788/4885LGALS1 695/4885 |
| US-20170101388-A1 | C-GLYCOSIDE DERIVATIVE | RDX, C1R, C3AR1 | PYGB 822/4885LGALS8 788/4885LGALS1 695/4885 |
| US-20070197623-A1 | NOVEL FLUOROGLYCOSIDE DERIVATIVES OF PYRAZOLES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THE USE THEREOF | DPP4, UGGT1, SLC5A2 | PYGB 936/4885LGALS8 108/4885LGALS1 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.